Simplex Trading
IMVT icon

Simplex Trading’s Immunovant IMVT Stock Holding History

Simplex Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
63,600
+53,500
+530% +$1.39M ﹤0.01% 2030
2025
Q4 		$257K Sell
10,100
-5,000
-33% -$111K ﹤0.01% 3976
2025
Q3 		$243K Buy
15,100
+10,600
+236% +$172K ﹤0.01% 4704
2025
Q2 		$72K Sell
4,500
-154,800
-97% -$2.34M ﹤0.01% 5555
2025
Q1 		$2.72M Buy
159,300
+78,300
+97% +$1.64M ﹤0.01% 1752
2024
Q4 		$2.01M Buy
81,000
+24,500
+43% +$695K ﹤0.01% 2189
2024
Q3 		$1.61M Sell
56,500
-22,200
-28% -$655K ﹤0.01% 2467
2024
Q2 		$2.08M Buy
78,700
+34,800
+79% +$990K ﹤0.01% 2166
2024
Q1 		$1.42M Sell
43,900
-81,600
-65% -$2.98M ﹤0.01% 2760
2023
Q4 		$5.29M Sell
125,500
-361,300
-74% -$13.3M ﹤0.01% 1500
2023
Q3 		$18.7M Buy
486,800
+476,400
+4,581% +$10.8M 0.01% 620
2023
Q2 		$197K Buy
10,400
+4,700
+82% +$87.6K ﹤0.01% 4308
2023
Q1 		$88K Buy
5,700
+5,000
+714% +$86.8K ﹤0.01% 5295
2022
Q4 		$12K Sell
700
-10,000
-93% -$126K ﹤0.01% 7365
2022
Q3 		$59K Buy
10,700
+10,400
+3,467% +$50.8K ﹤0.01% 6210
2022
Q2 		$1K Hold
300
– – ﹤0.01% 9600
2022
Q1 		$1K Sell
300
-27,400
-99% -$171K ﹤0.01% 10088
2021
Q4 		$236K Sell
27,700
-5,600
-17% -$46.2K ﹤0.01% 4932
2021
Q3 		$378K Hold
33,300
– – ﹤0.01% 4531
2021
Q2 		$351K Buy
33,300
+33,265
+95,043% +$464K ﹤0.01% 4715
2021
Q1 		$56K Buy
+35
New +$923 ﹤0.01% 6463

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Simplex Trading's IMVT Position: Q1 2026 in Review

Simplex Trading increased its Immunovant (IMVT) stake by 3.9% in Q1 2026, buying an estimated $48.3K and bringing the position to 50,276 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Simplex Trading first reported a position in IMVT in Q2 2021 and has held it in 18 quarters since. The position peaked at $4.81M in Q3 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Simplex Trading held 50,276 shares of Immunovant worth $1.25M as of Q1 2026.
  • Simplex Trading bought 1,865 Immunovant shares in Q1 2026, an estimated $48.3K.
  • Immunovant made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2270 holding.
  • Simplex Trading first reported a position in Immunovant in Q2 2021 and has held it in 18 quarters since.
  • Simplex Trading's Immunovant position peaked at $4.81M in Q3 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.